Search
for
Sort by
Research 121–150 of 1000+
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors
- Dacomitinib-Induced Paronychia Associated With PRIDE Syndrome in a Patient With Non-Small Cell Lung Cancer
- Brief Report: Requirement of TACE/ADAM17 for Hair Follicle Bulge Niche Establishment
- Epidermal Growth Factor as a Biologic Switch in Hair Growth Cycle
- Epidermal Growth Factor Induces Proliferation of Hair Follicle-Derived Mesenchymal Stem Cells Through Epidermal Growth Factor Receptor-Mediated Activation of ERK and AKT Signaling Pathways Associated with Upregulation of Cyclin D1 and Downregulation of p16
- Cetuximab-induced hypertrichosis of the scalp and eyelashes
- Drug Repurposing Patent Applications April–June 2021
- Allopregnanolone promotes proliferation and differential gene expression in human glioblastoma cells
- Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- A Case of Hair Change and Acneiform Eruption Induced by ZD1839 (Iressa$^{(R)}$)
- A linear and reticulate crusted keratotic papulopustular eruption: a rare presentation of PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) complex
- Epidermal growth factor receptor inhibitor Geftinib-induced erosive pustular dermatosis of the scalp – A report with a brief review of the literature
- Synthesis and biological activity evaluation of new isatin-gallate hybrids as antioxidant and anticancer agents (in vitro) and in silico study as anticancer agents and coronavirus inhibitors
- Non-small cell lung carcinoma spheroid models in agarose microwells for drug response studies
- “PRIDE” Complex
- 3D organotypic skin models recapitulate autoantibody-driven pemphigus pathomechanisms and targeted therapeutic response
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- PC-SPES Studies Promising, But Manufacturer Shuts Down
- Sorting Out the Seeming Increase in Lung Cancer in Women Who Have Never Smoked
- Amphiregulin in Fibrotic Diseases and Cancer
- Malignant epithelial tumors: Part II. Therapy and prevention
- Lady with Long Eyelashes…!
- The urine as a diagnostic key for a homozygous EGFR mutation
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- Abstract 1219: Defective catagen entry in EGFR deficient skin precedes cutaneous inflammation
- 6-Gingerol inhibits hair cycle via induction of MMP2 and MMP9 expression
- 129 Targeted inhibition of EGFR reduces anti-microbial defense mechanisms at the hair canal
- The patient outcomes with EGFR-mutated advanced non-small-cell lung cancer receiving aumolertinib as first-line treatment.